Rybelsus 14 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Z07
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,471
Award facts
- Contract value 100% obligated
- $38,470.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,470.74 to AmerisourceBergen Drug Corp for the supply of Rybelsus 14 mg tablets (30-count units) on January 21, 2026, with an ultimate completion date of January 22, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., is a critical federal vendor specializing in brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The delivery of Rybelsus—an oral diabetes medication—reflects the company's extensive portfolio of pharmaceutical supplies supporting military treatment facilities and veterans' healthcare programs. This award demonstrates AmerisourceBergen's continued capability to compete successfully for federal medical procurement requirements through open competition and its established role within the DLA's global pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F5Z07?
SPE2DR26F5Z07 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F5Z07 worth?
The government has obligated $38,471 on SPE2DR26F5Z07.
Is contract SPE2DR26F5Z07 an order under another contract?
Yes. SPE2DR26F5Z07 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Z07 competed?
The extent of competition for SPE2DR26F5Z07 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award